What active ingredient in callus softeners is an organic acid that has anti inflammatory?

1. Rendon Mi, Berson DS, Cohen JI, Roberts WE, Starker I, Wang B. Evidence and considerations in the application of chemical peels in skin disorders and aesthetic resurfacing. J Clin Aesthet Dermatol. 2010;3:32–43. [PMC free article] [PubMed] [Google Scholar]

2. Kornhauser A, Coelho SG, Hearing VJ. Applications of hydroxy acids: classification, mechanisms, and photoactivity. Clin Cosmet Investig Dermatol. 2010;3:135–142. [PMC free article] [PubMed] [Google Scholar]

3. Khunger N. Standard guidelines of care for chemical peels. Indian J Dermatol Venereol Leprol. 2008;74:S5–S12. [PubMed] [Google Scholar]

4. Lin AN, Nakatsui T. Salicylic acid revisited. Int J Dermatol. 1998;37:335–342. [PubMed] [Google Scholar]

5. Draelos ZD. Rediscovering the cutaneous benefits of salicylic acid. Cosm Derm. 1997;10(Suppl 4):4. [Google Scholar]

6. Grimes PE. Salicylic acid. In: Tosti A, Grimes PE, Padova MP, editors. Color Atlas of Chemical Peels. 2nd ed. New York, NY, USA: Springer-Verlag; 2006. [Google Scholar]

7. Brackett W. The chemistry of salicylic acid. Cosmet Derm. 1997;10(Suppl 4):5–6. [Google Scholar]

8. Kligman AM. Salicylic acid: an alternative to alpha-hydroxy acids. J Geriatr Dermatol. 1997;5:128–131. [Google Scholar]

9. Yu RJ, Van Scott EJ. Salicylic acid: not a beta-hydroxy acid. Cosmet Derm. 1997;10:27. [Google Scholar]

10. Baumann L, Saghari S. Chemical peels. In: Baumann L, Saghari S, Weisberg E, editors. Cosmetic Dermatology: Principles and Practice. 2nd ed. New York, NY, USA: McGraw-Hill Companies; 2009. [Google Scholar]

11. Draelos ZD. Salicylic acid in the dermatologic armamentarium. Cosmet Derm. 1997;10(Suppl 4):7–8. [Google Scholar]

12. Marczyk B, Mucha P, Budzisz E, Rotsztejn H. Comparative study of the effect of 50% pyruvic and 30% salicylic peels on the skin lipid film in patients with acne vulgaris. J Cosmet Dermatol. 2014;13:15–21. [PubMed] [Google Scholar]

13. Roberts DL, Marshall R, Marks R. Detection of the action of salicylic acid on the normal stratum corneum. Br J Dermatol. 1980;102:191–196. [PubMed] [Google Scholar]

14. Marks R, Davies M, Cattell A. An explanation for the keratolytic effect of salicylic acid. J Invest Dermatol. 1975;64:283. [Google Scholar]

15. Davies M, Marks RL. Studies on the effect of salicylic acid on normal skin. Br J Dermatol. 1976;95:187–192. [PubMed] [Google Scholar]

16. Lazo ND, Meine JG, Downing DT. Lipids are covalently attached to rigid corneocyte protein envelope existing predominantly as beta-sheets: a solid state nuclear magnetic resonance study. J Invest Dermatol. 1995;105:296–300. [PubMed] [Google Scholar]

17. Swinehart JM. Salicylic acid ointment peeling of the hands and forearms. Effective nonsurgical removal of pigmented lesions and actinic damage. J Dermatol Surg Oncol. 1992;18:495–498. [PubMed] [Google Scholar]

18. Aronsohn RB. Hand chemosurgery. Am J Cosmet Surg. 1984;1:24–28. [Google Scholar]

19. Imayama S, Ueda S, Isoda M. Histologic changes in the skin of hairless mice following peeling with salicylic acid. Arch Dermatol. 2000;136:1390–1395. [PubMed] [Google Scholar]

20. Del Rosso J. Pharmacotherapy update: current therapies and research for common dermatologic conditions. The many roles of topical salicylic acid. Skin Aging. 2005;13:38–42. [Google Scholar]

21. Weirich EG, Longauer JK, Kirkwood AH. Dermatopharmacology of salicylic acid. II. Epidermal anti-hyperplastic effect of salicylic acid in animals. Dermatologica. 1975;151:321–332. [PubMed] [Google Scholar]

22. Loden M, Bostrom P, Kneczke M. Distribution and keratolytic effect of salicylic acid and urea in human skin. Skin Pharmacol. 1995;8:173–178. [PubMed] [Google Scholar]

23. Burke A, Smyth E, Fitzgerald Garret A. Analgesic antipyretic and anti-inflammatory agents. In: Brunton LL, Lazo JS, Parker K, editors. Goodman and Gilman’s The Pharmacological Basis of Therapeutics. 11th ed. New York, NY, USA: McGraw-Hill; 2006. [Google Scholar]

24. Weirich EG, Longauer JK, Kirkwood AH. Dermatopharmacology of salicylic acid. III. Topical contra-inflammatory effect of salicylic acid and other drugs in animal experiments. Dermatologica. 1976;152:87–99. [PubMed] [Google Scholar]

25. Adam BH, Julio CC, Dana MK, Andrew NL. Agents used for treatment of hyperkeratosis. In: Wolverton SE, editor. Comprehensive Dermatologic Drug Therapy. 3rd ed. New York, NY, USA: Elsevier Saunders; 2013. [Google Scholar]

26. Wright S, Robertson VJ. An institutional survey of tinea capitis in Harare, Zimbabwe and a trial of miconazole cream versus Whitfield’s ointment in its treatment. Clin Exp Dermatol. 1986;11:371–377. [PubMed] [Google Scholar]

27. Draelos ZD. Atlas of Cosmetic Dermatology. New York, NY, USA: Churchill Livingstone; 2000. [Google Scholar]

28. Ueda S, Mitsugi K, Ichige K, et al. New formulation of chemical peeling agent: 30% salicylic acid in polyethylene glycol. Absorption and distribution of 14C-salicylic acid in polyethylene glycol applied topically to skin of hairless mice. J Dermatol Sci. 2002;28:211–218. [PubMed] [Google Scholar]

29. Dainichi T, Ueda S, Isoda M, et al. Chemical peeling with salicylic acid in polyethylene glycol vehicle suppresses skin tumour development in hairless mice. Br J Dermatol. 2003;148:906–912. [PubMed] [Google Scholar]

30. Hjorth N. Traditional topical treatment of acne. Acta Derm Venereol Suppl (Stockh) 1980;(Suppl 89):53–56. [PubMed] [Google Scholar]

31. Olsen TG. Therapy of acne. Med Clin North Am. 1982;66:851–871. [PubMed] [Google Scholar]

32. Olin B. Facts and Comparisons. St Louis, MO, USA: JB Lippincott Co; 1990. [Google Scholar]

33. Bowe WP, Shalita AR. Effective over-the-counter acne treatments. Semin Cutan Med Surg. 2008;27:170–176. [PubMed] [Google Scholar]

34. Monheit GD, Chastian MA. Chemical and mechanical skin resurfacing. In: Bolognia JL, Jorizzo JL, Rapini RP, editors. Dermatology. Philadelphia, PA, USA: Mosby; 2003. [Google Scholar]

35. Bourelly PE, Lotsikas-Baggili AJ. Chemexfoliation and superficial skin resurfacing. In: Burgess CM, editor. Cosmetic Dermatology. 1st ed. Heidelberg, Germany: Springer-Verlag; 2005. [Google Scholar]

36. Kligman D, Kligman AM. Salicylic acid peels for the treatment of photoaging. Dermatol Surg. 1998;24:325–328. [PubMed] [Google Scholar]

37. Skin Inc The Fitzpatrick Skin Type Classification Scale. Nov, 2007. [Accessed January 7, 2014]. Available from: http://www.skininc.com/skinscience/physiology/10764816.html.

38. Grimes PE. The safety and efficacy of salicylic acid chemical peels in darker racial-ethnic groups. Dermatol Surg. 1999;25:18–22. [PubMed] [Google Scholar]

39. Mendelsohn JE. Update on chemical peels. Otolaryngol Clin North Am. 2002;35:55–72. [PubMed] [Google Scholar]

40. Lee HS, Kim IH. Salicylic acid peels for the treatment of acne vulgaris in Asian patients. Dermatol Surg. 2003;29:1196–1199. [PubMed] [Google Scholar]

41. Kvorning SA. On ointments containing salicylic acid. Acta Dermatol Venereol. 1954;34:89–91. [PubMed] [Google Scholar]

42. Stolar ME, Rossi GV, Barr M. The effect of various ointment bases on the percutaneous absorption of salicylates. I. Effect of type of ointment base. J Am Pharm Assoc. 1960;49:144–147. [PubMed] [Google Scholar]

43. Taylor JR, Halprin KM. Percutaneous absorption of salicylic acid. Arch Dermatol. 1975;111:740–743. [PubMed] [Google Scholar]

44. Lindsey CP. Two cases of fatal salicylate poisoning after topical application of an antifungal solution. Med J Aust. 1968;1:353–354. [PubMed] [Google Scholar]

45. Fung W, Orak D, Re TA, Haughey DB. Relative bioavailability of salicylic acid following dermal application of a 30% salicylic acid skin peel preparation. J Pharm Sci. 2008;97:1325–1328. [PubMed] [Google Scholar]

46. Raschke R, Arnold-Capell PA, Richeson R, et al. Refractory hypoglycemia secondary to topical salicylate intoxication. Arch Intern Med. 1991;151:591–593. [PubMed] [Google Scholar]

47. Goh CL, Ng SK. Contact allergy to salicylic acid. Contact Dermatitis. 1986;14:114. [PubMed] [Google Scholar]

48. Lachapelle J-M, Leroy B. Allergic contact dermatitis to colophony included in the formulation of flexible collodion BP, the vehicle of salicylic and lactic acid wart paint. Dermatol Clin. 1990;8:143–146. [PubMed] [Google Scholar]

49. Kinsley M, Metelitsa AI, Somani AK. Chemical peels. In: Wolverton SE, editor. Comprehensive Dermatologic Drug Therapy. 3rd ed. New York, NY, USA: Elsevier Saunders; 2013. [Google Scholar]

Page 2

Various concentrations of SA used in dermatology and cosmetics